beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc

Term ID

CHEBI:71411

Synonyms

2-(acetylamino)-6-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-2-deoxy-alpha-D-galactopyranose
2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->6)-2-acetamido-2-deoxy-alpha-D-galactopyranose
2-acetamido-6-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-alpha-D-galactopyranose
beta-D-GlcNAc-(1->6)-alpha-D-GalNAc
GlcNAcb1-6GalNAca
GlcNAcbeta1-6GalNAcalpha
N-acetyl-beta-D-glucosaminyl-(1->6)-N-acetyl-alpha-D-galactosamine

Definition

β-D-GlcpNAc-(1→6)-D-GalpNAc in which the anomeric configuration of the reducing-end GalNAc residue is α.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc

Phenotype where environments contain beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc

Phenotype modified by environments containing beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc

Phenotype affecting beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc

Human Disease Model